Version 1
: Received: 2 July 2020 / Approved: 5 July 2020 / Online: 5 July 2020 (07:40:57 CEST)
How to cite:
Dutta, S.; Bandyopadhyay, S. K. Heterogeneity Aspects of Breast for Breast Cancer Patients Change due to COVID-19. Preprints2020, 2020070052. https://doi.org/10.20944/preprints202007.0052.v1
Dutta, S.; Bandyopadhyay, S. K. Heterogeneity Aspects of Breast for Breast Cancer Patients Change due to COVID-19. Preprints 2020, 2020070052. https://doi.org/10.20944/preprints202007.0052.v1
Dutta, S.; Bandyopadhyay, S. K. Heterogeneity Aspects of Breast for Breast Cancer Patients Change due to COVID-19. Preprints2020, 2020070052. https://doi.org/10.20944/preprints202007.0052.v1
APA Style
Dutta, S., & Bandyopadhyay, S. K. (2020). Heterogeneity Aspects of Breast for Breast Cancer Patients Change due to COVID-19. Preprints. https://doi.org/10.20944/preprints202007.0052.v1
Chicago/Turabian Style
Dutta, S. and Samir Kumar Bandyopadhyay. 2020 "Heterogeneity Aspects of Breast for Breast Cancer Patients Change due to COVID-19" Preprints. https://doi.org/10.20944/preprints202007.0052.v1
Abstract
Breast cancer develops from cells lining the milk ducts and slowly grows into a lump or a tumour. Breast cancer may be invasive or non-invasive. Invasive cancer spreads from the milk duct or lobule to other tissues in the breast, whereas, non-invasive ones lack the ability to invade other breast tissues. Non-invasive breast cancer is called in situ and may remain inactive for entire lifetime. Due to heterogeneity nature of breast, density as well as masses is variable in size and shape. A dataset of 18056 patients are collected from 20 Government Hospitals and 50 Private Hospitals in West Bengal before COVID-19 and after COVID-19. The classification of patients are made on three classes- Normal, Sign of Abnormality and Abnormality. The reports of MRIs of patients in January 2020 and February 2020 are collected from different hospitals. It is treated as dataset before COVID-19 . MRIS of patients in April 2020 and May 2020 are dataset during COVID-19. The entire datasets are accumulated for testing of any change in patients MRIS after the official announcement of new virus COVID-19 in March 2020. The aim of the paper is to make a comparison of any change in size and shape of masses of MRIs of patients before and after COVId-19. All collected MRIs reports are diagnosed by radiologists of hospitals.
Keywords
COVID-19; Breast Cancer; Breast Cancer (Suspected); Mammogram Images and Invasive Cancer
Subject
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.